-
1
-
-
0001716873
-
A nerve growth stimulating factor isolated from snake venom
-
Cohen S, Levi-Montalcini R. 1956. A nerve growth stimulating factor isolated from snake venom. Proc. Natl. Acad. Sci. 42:571-574
-
(1956)
Proc. Natl. Acad. Sci.
, vol.42
, pp. 571-574
-
-
Cohen, S.1
Levi-Montalcini, R.2
-
3
-
-
0035112322
-
The trenches with Viktor Hamburger and Rita-Levi Montalcini (1965-1974): One student's perspective
-
Provine R. 2001. In the trenches with Viktor Hamburger and Rita-Levi Montalcini (1965-1974): one student's perspective. Int. J. Dev. Neurosci. 19:143-149
-
(2001)
Int. J. Dev. Neurosci.
, vol.19
, pp. 143-149
-
-
Provine, R.1
-
4
-
-
0034917953
-
Viktor Hamburger and Rita Levi-Montalcini: The path to the discovery of nerve growth factor
-
Cowan W. 2001. Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor. Annu. Rev. Neurosci. 24:551-600
-
(2001)
Annu. Rev. Neurosci.
, vol.24
, pp. 551-600
-
-
Cowan, W.1
-
5
-
-
0023236055
-
The nerve growth factor: Thirty-five years later
-
Levi-Montalcini R. 1987. The nerve growth factor: thirty-five years later. Science 237:1154-1164
-
(1987)
Science
, vol.237
, pp. 1154-1164
-
-
Levi-Montalcini, R.1
-
6
-
-
59249103525
-
Origins of growth factors: NGF and EGF
-
Cohen S. 2008. Origins of growth factors: NGF and EGF. J. Biol. Chem. 283:33793-33797
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 33793-33797
-
-
Cohen, S.1
-
7
-
-
0001228725
-
Purification and metabolic effects of a nerve growth-promoting protein from snake venom
-
Cohen S. 1959. Purification and metabolic effects of a nerve growth-promoting protein from snake venom. J. Biol. Chem. 234:1129-1137
-
(1959)
J. Biol. Chem.
, vol.234
, pp. 1129-1137
-
-
Cohen, S.1
-
8
-
-
21044458854
-
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
-
Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, et al. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11:551-555
-
(2005)
Nat. Med.
, vol.11
, pp. 551-555
-
-
Tuszynski, M.H.1
Thal, L.2
Pay, M.3
Salmon, D.P.4
S, U.H.5
-
9
-
-
62049083420
-
Neuroprotective effects of brainderived neurotrophic factor in rodent and primate models of Alzheimer's disease
-
Nagahara A, Merrill D, Coppola G,Tsukada S, Schroeder B, et al. 2009. Neuroprotective effects of brainderived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 15:331-337
-
(2009)
Nat. Med.
, vol.15
, pp. 331-337
-
-
Nagahara, A.1
Merrill, D.2
Coppola Gtsukada, S.3
Schroeder, B.4
-
10
-
-
34047130812
-
Role of brain-derived neurotrophic factor in Huntington's disease
-
Zuccato C, Cattaneo E. 2007. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 81:294-330
-
(2007)
Prog. Neurobiol.
, vol.81
, pp. 294-330
-
-
Zuccato, C.1
Cattaneo, E.2
-
11
-
-
34548336779
-
New insights into BDNF function in depression and anxiety
-
Martinowich K, Manji H, Lu B. 2007. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10:1089-1093
-
(2007)
Nat. Neurosci.
, vol.10
, pp. 1089-1093
-
-
Martinowich, K.1
Manji, H.2
Lu, B.3
-
12
-
-
0029999022
-
Synaptic modulation by neurotrophic factors: Differential and synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor
-
Stoop R, Poo M-M. 1996. Synaptic modulation by neurotrophic factors: differential and synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor. J. Neurosci. 16:3256-3264
-
(1996)
J. Neurosci.
, vol.16
, pp. 3256-3264
-
-
Stoop, R.1
Poo, M.-M.2
-
13
-
-
0037359267
-
BDNF and activity-dependent synaptic modulation
-
Lu B. 2003. BDNF and activity-dependent synaptic modulation. Learning Memory 10:86-98
-
(2003)
Learning Memory
, vol.10
, pp. 86-98
-
-
Lu, B.1
-
14
-
-
33748632656
-
Brain-derived nerotrophic factor mechanisms and function in adult synaptic plasticity: New insights and implications for therapy
-
Kuipers S, Bramham C. 2006. Brain-derived nerotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr. Opin. Drug Discov. Dev. 9:580-586
-
(2006)
Curr. Opin. Drug Discov. Dev.
, vol.9
, pp. 580-586
-
-
Kuipers, S.1
Bramham, C.2
-
15
-
-
18244369738
-
Nerve growth factor rapidly increases muscarinic tone in mouse medial septum/diagonal band of Broca
-
15a
-
Wu C, Yeh H. 2005. Nerve growth factor rapidly increases muscarinic tone in mouse medial septum/diagonal band of Broca. J. Neurosci. 25:4232-42 15a
-
(2005)
J. Neurosci.
, vol.25
, pp. 4232-4242
-
-
Wu, C.1
Yeh, H.2
-
16
-
-
69849091630
-
NGF is essential for hippocampal plasticity and learning
-
Connor JM, Franks KM, Titterness AK, Russell K, Merrill DA, et al. 2009. NGF is essential for hippocampal plasticity and learning. J. Neurosci. 29:10883-10889
-
(2009)
J. Neurosci.
, vol.29
, pp. 10883-10889
-
-
Connor, J.M.1
Franks, K.M.2
Titterness, A.K.3
Russell, K.4
Merrill, D.A.5
-
17
-
-
0034142063
-
Trophic factors: An evolutionary cul-de sac or door into higher neuronal function?
-
Chao MV. 2000. Trophic factors: an evolutionary cul-de sac or door into higher neuronal function? J. Neurosci. Res. 59:353-355
-
(2000)
J. Neurosci. Res.
, vol.59
, pp. 353-355
-
-
Chao, M.V.1
-
18
-
-
31844438588
-
Novel class of pain drugs based on antagonism of NGF
-
Hefti F, Rosenthal A, Walicke P, Wyatt S, Vergara G, et al. 2006. Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol. Sci. 27:85-91
-
(2006)
Trends Pharmacol. Sci.
, vol.27
, pp. 85-91
-
-
Hefti, F.1
Rosenthal, A.2
Walicke, P.3
Wyatt, S.4
Vergara, G.5
-
19
-
-
20444498114
-
Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis
-
Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A. 2005. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 116:8-16
-
(2005)
Pain
, vol.116
, pp. 8-16
-
-
Shelton, D.L.1
Zeller, J.2
Ho, W.H.3
Pons, J.4
Rosenthal, A.5
-
20
-
-
47249145680
-
Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type i
-
Sabasovich I, Wei T, Guo T, Zhao R, Shi X, et al. 2008. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 138:47-60
-
(2008)
Pain
, vol.138
, pp. 47-60
-
-
Sabasovich, I.1
Wei, T.2
Guo, T.3
Zhao, R.4
Shi, X.5
-
21
-
-
33847325329
-
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain
-
Ugolini G, Marinelli S, Covaceuszach S, Cattaneo A, Pavone F. 2007. the function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc. Natl. Acad. Sci. USA 104:2985-2990
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 2985-2990
-
-
Ugolini, G.1
Marinelli, S.2
Covaceuszach, S.3
Cattaneo, A.4
Pavone, F.5
-
22
-
-
33748375335
-
Neurotrophins: Mediators and modulators of pain
-
Peret S, McMahon SB. 2006. Neurotrophins: mediators and modulators of pain. Annu. Rev. Neurosci. 29:507-538
-
(2006)
Annu. Rev. Neurosci.
, vol.29
, pp. 507-538
-
-
Peret, S.1
McMahon, S.B.2
|